Your session is about to expire
Tumor Markers For Breast Cancer: What You Need To Know
Background on Tumor Markers
Tumor markers, also known as biomarkers, are substances in the body. They are often proteins. Tumors or cancer cells produce these markers.
Not all tumors make tumor markers. In some cases, non-cancerous conditions can cause these markers to increase. A single tumor marker test is not enough for a cancer diagnosis.
Many organs can have these biomarkers such as breast, lung, colon and prostate. Doctors use tests to find these markers in blood, urine or tissue samples.
The role of tumor markers has expanded over time due to medical research advances. Today they help in screening for early stage cancers and monitoring response to treatment.
Tumor Markers in Breast Cancer
Tumor markers are substances in the body. They increase when cancer is present. In breast cancer, these include CA 15-3 andCA 27-29.
Breast cancer cells produce CA 15-3 andCA 27-29. When these rise, it may mean breast cancer is growing. However, other conditions can also cause a rise. These include liver disease or ovarian cysts.
These tumor markers help monitor treatment response. If levels drop after therapy, it suggests successful treatment. But if they go up despite therapy, changes may be necessary.
It's important to remember that these tests aren't perfect for diagnosis alone. Doctors use them along with imaging studies and biopsies for accurate diagnoses.
Imaging Tests for Recurrence
Imaging tests help check for cancer recurrence. These are medical procedures that doctors use to see inside your body. They provide visuals of areas where cancer may have returned.
Common imaging tests include CT scans, MRI, and PET scans. A CT scan uses X-rays to create detailed pictures of organs and tissues. An MRI uses powerful magnets and radio waves for the same purpose. A PET scan shows how tissues and organs are functioning.
These tests can detect changes in size or shape of tumors if they exist, or new growths elsewhere in the body. Patients usually get these tests at regular intervals after treatment ends.
Remember, you play an essential role in managing your health care journey - ask questions about what each test involves! Be proactive; knowing more will always give you better control over your healthcare decisions.
ASCO's Recommendation
The American Society of Clinical Oncology (ASCO) strongly advocates for clinical trials. They view them as critical in improving cancer care. Their primary recommendation is that every patient should learn about and consider joining a clinical trial.
Clinical trials help discover new treatments. They test if these are better than existing ones. It's important to note, ASCO says not all patients will qualify for every trial. Trials have specific eligibility criteria based on factors like age, type of cancer, treatment history and overall health.
ASCO also recommends talking to your doctor about potential risks and benefits. This helps make informed decisions about participating in a trial. Remember, it's always the patient's choice whether or not to participate in a clinical trial.
In summary: Learn about available trials, evaluate your eligibility with your doctor's assistance, discuss potential risks and benefits, then decide if participation is right for you.
Implications for Patients
Clinical trials have direct implications for patients. They offer a chance to access new treatments before they are widely available. These trials test the safety and effectiveness of these treatments.
Patients participating in clinical trials play an active role in their own healthcare. They contribute to medical research that could benefit future patients. However, there are risks involved.
Trials can involve unknown side effects or less effective treatment than standard care options. Patients must weigh these potential drawbacks against the possible benefits.
Understanding and navigating clinical trials requires effort and time from patients; it is not always straightforward. Researching, asking questions, and discussing with your healthcare provider is essential.
In summary, participation in a clinical trial offers potential benefits but also carries inherent risks. It's crucial that patients do their homework before deciding to participate.
Additional Information Resources.
Clinical trials are complex. Additional resources help you understand them better. These include websites, books, and support groups.
Firstly, websites offer vast information. The U.S National Library of Medicine's www.clinicaltrials.gov is a good start. It provides details on worldwide clinical trials. The World Health Organization’s (WHO) International Clinical Trials Registry Platform is also useful.
Secondly, books provide in-depth knowledge. 'The Patient's Guide To Medical Research' by Jill Russel simplifies the process of understanding clinical trials.
Thirdly, support groups give emotional backing and practical advice from people with similar experiences.
Remember to consult your healthcare provider before making any decisions based on these resources.